Clover Health Investments, Corp. (CLOV) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Clover Health Investments, Corp. (CLOV) Healthcare & Pipeline Overview

Clover Health Investments, Corp. is a technology-driven Medicare Advantage insurer, providing health plans through its Clover Assistant platform. The company focuses on leveraging data and technology to improve healthcare outcomes for Medicare-eligible consumers in the United States, differentiating itself through its software-centric approach within the healthcare sector.

What Is the Investment Thesis for CLOV?

The company's Clover Assistant platform aims to improve healthcare outcomes and reduce costs by providing physicians with real-time data and insights. With a gross margin of 42.5%, Clover Health demonstrates its ability to generate value from its insurance offerings. Key growth catalysts include expanding its geographic footprint and increasing penetration within existing markets. However, potential risks include regulatory changes in the healthcare industry and competition from larger, more established players. The company's current market capitalization is $2.44B, reflecting investor sentiment regarding its growth potential and profitability challenges. Achieving profitability, indicated by its current profit margin of -2.6%, remains a critical factor for long-term success.

Based on FMP financials and quantitative analysis

CLOV Key Highlights

Market Cap of $2.44B reflects investor valuation of Clover Health's growth potential in the Medicare Advantage market.

• Gross Margin of 42.5% indicates the company's ability to generate value from its insurance offerings and manage healthcare costs effectively.
• Profit Margin of -2.6% highlights the company's ongoing efforts to achieve profitability and scale its operations efficiently.
• Beta of 2.25 suggests higher volatility compared to the market, reflecting the growth stage and potential risks associated with the company.
• Clover Assistant platform is a key differentiator, providing physicians with real-time data and insights to improve patient care and reduce costs.

Who Are CLOV's Competitors?

CLOV is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are CLOV's Key Strengths?

Technology-driven platform (Clover Assistant) for data analytics and care management.

• Focus on value-based care and improved healthcare outcomes.
• Partnerships with physicians and healthcare providers.
• Experienced management team with expertise in healthcare and technology.

What Are CLOV's Weaknesses?

Relatively small market share compared to larger competitors.

• Profitability challenges and ongoing losses.
• Dependence on government regulations and reimbursement rates.
• Limited geographic presence compared to national players.

What Could Drive CLOV Stock Higher?

Expansion into new geographic markets, increasing the company's reach and potential customer base.

• Continued development and enhancement of the Clover Assistant platform, improving its capabilities and value proposition.
• Strategic partnerships with healthcare providers and organizations, expanding the company's network and access to patients.
• Focus on value-based care initiatives, aligning incentives and improving healthcare outcomes.

What Are the Key Risks for CLOV?

Negative return on equity (-17.1%) — the business is not currently generating profit on shareholder capital.

• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Insider selling — insiders were net sellers of roughly $5.8M recently.
• Regulatory changes and reimbursement rate cuts in the healthcare industry, impacting the company's revenue and profitability.
• Competition from larger, more established players in the Medicare Advantage market, limiting the company's growth potential.
• Economic downturn and decreased consumer spending, affecting the company's ability to attract and retain members.
• Cybersecurity risks and data breaches, compromising patient information and damaging the company's reputation.
• Achieving and maintaining profitability, given the company's history of losses.

What Are the Growth Opportunities for CLOV?

• Geographic Expansion: Clover Health has the opportunity to expand its geographic footprint by entering new markets and offering its Medicare Advantage plans to a broader population. This expansion can be achieved through strategic partnerships, acquisitions, or organic growth initiatives. The Medicare Advantage market is projected to continue growing, providing ample opportunities for Clover Health to increase its market share and revenue. Timeline: Ongoing.
• Increased Penetration in Existing Markets: Clover Health can focus on increasing its market share within its existing markets by enhancing its marketing efforts, improving its product offerings, and strengthening its relationships with physicians and healthcare providers. By providing superior service and value to its members, Clover Health can attract new customers and retain existing ones. Timeline: Ongoing.
• Expansion of Clover Assistant Platform: Clover Health can further develop and expand the capabilities of its Clover Assistant platform to provide additional value to physicians and patients. This can include incorporating new features, integrating with other healthcare systems, and leveraging data analytics to improve healthcare outcomes. Timeline: Ongoing.
• Strategic Partnerships and Acquisitions: Clover Health can pursue strategic partnerships and acquisitions to expand its capabilities, enter new markets, and gain access to new technologies. This can include partnering with healthcare providers, technology companies, or other healthcare organizations. Timeline: Ongoing.
• Focus on Non-Insurance Businesses: Clover Health can continue to develop and expand its non-insurance businesses to diversify its revenue streams and reduce its reliance on its insurance offerings. This can include providing healthcare services, developing healthcare technology solutions, or offering other related products and services. Timeline: Ongoing.

What Are CLOV's Competitive Advantages?

• Technology-driven platform (Clover Assistant) provides a competitive edge in data analytics and care management.
• Focus on value-based care aligns incentives and improves healthcare outcomes.
• Partnerships with physicians and healthcare providers create a network effect.
• Proprietary data and insights provide a competitive advantage in risk management and cost control.

What Does CLOV Do?

Clover Health Investments, Corp., founded in 2014 and headquartered in Franklin, Tennessee, operates as a Medicare Advantage insurer in the United States. The company distinguishes itself through its technology-driven approach to healthcare, primarily through its Clover Assistant platform. This software is designed to provide preferred provider organization (PPO) and health maintenance organization (HMO) health plans for Medicare-eligible consumers. Clover Health's core mission revolves around improving healthcare outcomes and reducing costs by leveraging data analytics and technology to empower physicians and patients. The Clover Assistant platform provides physicians with real-time data and insights, enabling them to make more informed decisions regarding patient care. This technology aims to enhance the quality of care, improve patient engagement, and streamline administrative processes. Clover Health's business model focuses on providing comprehensive healthcare coverage while simultaneously driving efficiency and innovation within the healthcare system. In addition to its insurance offerings, Clover Health also focuses on non-insurance businesses, further diversifying its revenue streams and expanding its reach within the healthcare industry. The company's strategic focus on technology and data analytics positions it as a disruptor in the traditional Medicare Advantage market, with the goal of delivering better healthcare outcomes at lower costs.

What Products and Services Does CLOV Offer?

• Provides Medicare Advantage health plans to eligible consumers in the United States.
• Operates the Clover Assistant, a software platform for healthcare providers.
• Offers preferred provider organization (PPO) and health maintenance organization (HMO) plans.
• Focuses on improving healthcare outcomes through data analytics and technology.
• Partners with physicians to provide better care and reduce costs.
• Engages in non-insurance businesses to diversify revenue streams.

How Does CLOV Make Money?

• Generates revenue from premiums paid by Medicare Advantage members.
• Utilizes the Clover Assistant platform to manage healthcare costs and improve outcomes.
• Partners with healthcare providers to deliver care to its members.
• Focuses on value-based care to align incentives and improve quality.

What Industry Does CLOV Operate In?

Clover Health operates within the dynamic and competitive Medicare Advantage market, which is experiencing significant growth due to the aging population and increasing demand for comprehensive healthcare coverage. The industry is characterized by a mix of established players, such as UnitedHealth Group and Humana, and emerging technology-driven companies like Clover Health. Market trends include a growing emphasis on value-based care, data analytics, and personalized healthcare solutions. Clover Health's technology-centric approach and focus on improving healthcare outcomes position it as a potential disruptor in this evolving landscape.

Who Are CLOV's Key Customers?

• Medicare-eligible individuals seeking comprehensive healthcare coverage.
• Physicians and healthcare providers who use the Clover Assistant platform.
• Healthcare organizations that partner with Clover Health to improve care delivery.

Company Profile

Clover Health Investments, Corp. operates in the Medical - Healthcare Plans industry within the Healthcare sector. It is headquartered in Wilmington, US. The company is led by CEO Andrew Toy. CLOV has traded publicly since 2020.

Return on equity for Clover Health Investments, Corp. stands at -17.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -8.2%, showing how much profit it generates from its asset base. Its free cash flow yield is 2.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.33 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -2.1%, the inverse of the P/E and a quick read on earnings relative to price.

CLOV Valuation & Market Position

With a $2.44B market cap, Clover Health Investments, Corp. sits in the mid-cap segment of the market. Analyst price targets span from $5.00 to $6.00, with a consensus of $5.50. At the current price of $4.71, that implies approximately 17% upside potential. Relative to its peer group, CLOV's quantitative score of 37/100 is below the peer average of 71/100.

Quarterly Financial Performance: Clover Health Investments, Corp.

Revenue for Clover Health Investments, Corp. came in at $743.2M during Q2 FY2026. The company recorded net income of $28.0M, with diluted EPS of $0.05. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Healthcare. Across the four most recent quarters, CLOV averaged $-0.01 in diluted EPS.

Clover Health Investments, Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 3.54 places it in the safe zone, indicating low near-term bankruptcy risk.

Clover Health Investments, Corp. has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses. Reported results have landed about 27.7% below estimates on average.

Over the past six months, Clover Health Investments, Corp. insiders filed 39 SEC Form 4 transactions — 32 sales and 7 purchases. On net that is roughly 515K shares acquired (about $5.8M) — insiders putting money in tends to read as conviction.

CLOV Financials

CLOV Latest News

CLOV Analyst Consensus

CLOV MoonshotScore

Common Questions About CLOV (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources